A systematic review of population based epidemiological studies in Myasthenia Gravis.
BACKGROUND
The aim was to collate all myasthenia gravis (MG) epidemiological studies including AChR MG and MuSK MG specific studies. To synthesize data on incidence rate (IR), prevalence rate (PR) and mortality rate (MR) of the condition and investigate the influence of environmental and technical factors on any trends or variation observed.


METHODS
Studies were identified using multiple sources and meta-analysis performed to calculate pooled estimates for IR, PR and MR.


RESULTS
55 studies performed between 1950 and 2007 were included, representing 1.7 billion population-years. For All MG estimated pooled IR (eIR): 5.3 per million person-years (C.I.:4.4, 6.1), range: 1.7 to 21.3; estimated pooled PR: 77.7 per million persons (C.I.:64.0, 94.3), range 15 to 179; MR range 0.1 to 0.9 per millions person-years. AChR MG eIR: 7.3 (C.I.:5.5, 7.8), range: 4.3 to 18.0; MuSK MG IR range: 0.1 to 0.32. However marked variation persisted between populations studied with similar methodology and in similar areas.


CONCLUSIONS
We report marked variation in observed frequencies of MG. We show evidence of increasing frequency of MG with year of study and improved study quality. This probably reflects improved case ascertainment. But other factors must also influence disease onset resulting in the observed variation in IR across geographically and genetically similar populations.
Carr
Aisling S
AS
Department of Neurology, Royal Victoria Hospital, Belfast, Northern Ireland, UK. aisling.carr@belfasttrust.hscni.net
Cardwell
Chris R
CR
McCarron
Peter O
PO
McConville
John
J
D006801:Humans; D015994:Incidence; D009157:Myasthenia Gravis / Q000453:epidemiology* / Q000401:mortality; D015995:Prevalence